- Global Pharma News & Resources

ABPI Board announces Kate Brunner QC appointed as new Chair of the PMCPA Appeal Board

 The ABPI Board is pleased to announce that Kate Brunner QC has been appointed Chair of the PMCPA Appeal Board. This follows the announcement that the current Chair, Mr William Harbage QC, is stepping down from the role at the end of 2020, after 15 years in the role.

ABPI President and Chair of the ABPI Board, Haseeb Ahmad, said:

“The ABPI Board welcomes Kate Brunner QC into the role of Chair of the PMCPA Appeal Board. Ms Brunner brings a huge breadth of experience to the role, across a wide-ranging legal practice including criminal, regulatory, and healthcare law. I look forward to working with Kate and the PMCPA to ensure there is a smooth transition in the new year.”

Kate Brunner QC said:

“I am delighted to take on such an important role as the independent Chair of the PMCPA Appeal Board.

“The PMCPA plays a critical role in upholding the high standards under which the industry operates, and I’m committed to using my experience to champion successful self-regulation in the pharmaceutical industry.”  

Editor Details

  • Company:
    • ABPI
  • Name:
    • ABPI
Last Updated: 15-Dec-2020